SCHEMBL21035635

SCHEMBL21035635

C[C@H](c1ccc(-c2ccc(Cl)cc2)cc1)N1CCN(S(=O)(=O)c2ccc(OCC3CCCCC3)cc2)[C@H](C2OC2N2CCC(NC(=O)OC(C)(C)C)CC2)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 3/20 0.38
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
KDM4D Q6B0I6 4/20 0.33
KDM6A O15550 1/20 0.33
BCL2L1 Q07817 1/20 0.33
MCL1 Q07820 1/20 0.33
MMP13 P45452 3/20 0.32
MMP1 P03956 2/20 0.32
ADAM17 P78536 2/20 0.32
MMP3 P08254 1/20 0.32
ALOX5 P09917 1/20 0.32
EPHX2 P34913 1/20 0.32
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32
APH1B Q8WW43 1/20 0.32
NCSTN Q92542 1/20 0.32
APH1A Q96BI3 1/20 0.32
PSENEN Q9NZ42 1/20 0.32
CCR5 P51681 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21035628 0.86 KMT2A (0.40) ACACBCHRM2CHRM1MMP13MMP1
SCHEMBL21035631 0.77 CHRM2 (0.42) CHRM2CHRM1BCL2L1MCL1MMP13
SCHEMBL21035630 0.77 CHRM2 (0.42) CHRM2CHRM1BCL2L1MCL1MMP13
SCHEMBL21035632 0.77 CHRM2 (0.43) CHRM2CHRM1BCL2L1MCL1MMP1
SCHEMBL21035634 0.77 CHRM2 (0.43) CHRM2CHRM1BCL2L1MCL1MMP1
SCHEMBL21035070 0.75 MMP1 (0.43) MMP13MMP1ADAM17MMP3ALOX5
SCHEMBL21035598 0.75 MMP1 (0.43) MMP13MMP1ADAM17MMP3ALOX5
SCHEMBL21035340 0.75 MEN1 (0.41) MMP13MMP1ADAM17MMP3ALOX5
SCHEMBL21035600 0.75 MEN1 (0.41) MMP13MMP1ADAM17MMP3ALOX5
SCHEMBL21035442 0.75 MEN1 (0.41) MMP13MMP1ADAM17MMP3ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed